Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Adverum Biotechnologies, Inc.
Adverum Biotechnologies Inc is a gene therapy company committed to discovering and developing novel medicines that can offer potentially life-changing therapeutic benefit to patients living with rare diseases or diseases of the eye.
IPO Date: May 12, 2016
Sector: Healthcare
Industry: Biotech
Market Cap: $54.94M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.20 | 3.64%
Avg Daily Range (30 D): $0.10 | 4.13%
Avg Daily Range (90 D): $0.16 | 5.10%
Institutional Daily Volume
Avg Daily Volume: .73M
Avg Daily Volume (30 D): .16M
Avg Daily Volume (90 D): .25M
Trade Size
Avg Trade Size (Sh.): 172
Avg Trade Size (Sh.) (30 D): 99
Avg Trade Size (Sh.) (90 D): 120
Institutional Trades
Total Inst.Trades: 1,061
Avg Inst. Trade: $1.82M
Avg Inst. Trade (30 D): $1.7M
Avg Inst. Trade (90 D): $1.59M
Avg Inst. Trade Volume: .04M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.18M
Avg Closing Trade (30 D): $4.03M
Avg Closing Trade (90 D): $4.03M
Avg Closing Volume: 33.19K
   
News
Jul 16, 2025 @ 11:00 AM
Presenting on Emerging Growth Conference 84 Day 2 ...
Source: Emerginggrowth.Com
Jul 15, 2025 @ 11:00 AM
Presenting on Emerging Growth Conference 84 Day 1 ...
Source: Emerginggrowth.Com
Jul 14, 2025 @ 8:47 AM
Wet Age-Related Macular Degeneration (Wet AMD) Mar...
Source: Researchandmarkets.Com
Jul 10, 2025 @ 5:27 PM
Biologic Competition, Payer Pressures, and Gene Th...
Source: Spherix Global Insights
Apr 17, 2025 @ 4:58 PM
INVESTOR ALERT: Pomerantz Law Firm Investigates Cl...
Source: N/A
Financials
  TTM Q1 2025 Q4 2024
Basic EPS $-7.24 $-2.25 $-1.98
Diluted EPS $-7.24 $-2.25 $-1.98
Revenue $ 1M $ M $ M
Gross Profit $ $ $
Net Income / Loss $ -150.8M $ -47.02M $ -40.93M
Operating Income / Loss $ -158.18M $ -48.22M $ -42.62M
Cost of Revenue $ $ $
Net Cash Flow $ -88.96M $ M $ -32.2M
PE Ratio    
Splits
Mar 21, 2024:   1:10